584 articles published
A government study suggests that covering medical cannabis through workers' compensation programs improved health outcomes and reduced opioid reliance.
Researchers tracked 1,700 adults over 20 years and found frequent TV viewers had smaller memory-related brain regions.
The FDA classified the recall as Class II on July 17, covering 12 products in seven dosage strengths distributed by Major Pharmaceuticals and Cardinal Health.
SIMTRIYO, made by Otsuka Pharmaceutical, is a daily tablet approved for patients as young as six who weigh at least 44 pounds.
A patient reduced his surgical bill from $23,000 to under $5,000 by comparing prices at different facilities before scheduling the procedure.
A new study tested OpenEvidence, OpenAI, Anthropic, and Doximity and found the same underlying problem in how they handle medical information.
A court ruling prevents the Trump administration from cutting mental health funding to nine school districts in Washington state.
The decision to eliminate the low-income subsidy program would affect Medicare beneficiaries who rely on it to cover prescription drug costs.
Health officials say new case counts appear to be declining following a recall of romaine lettuce linked to the parasitic illness.
Researchers used mice to show that genetic inheritance plays a role in determining how the body responds to DNA mutations that can become cancerous.
Researchers found that a simple daily stretching habit produced measurable benefits for both physical pain and psychological wellbeing.
Each tablet combines 325 mg of acetaminophen with 110 mg of naproxen sodium, and the drug is expected to reach retail shelves soon.
We use cookies to improve your experience and serve relevant ads. See our Privacy Policy for details.
